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Abstract
Background: Cross-country comparisons of health system performance have become increasingly important. Clear
evidence is needed on the prioritization of health system performance assessment (HSPA) indicators. Selected
“leading” or “headline” HSPA indicators may provide early warnings of policy impacts. The goal of this paper is to
propose a set of headline indicators to frame and describe health system performance.
Methods: We identified overlaps and gaps in the availability of reported indicators by looking at HSPA initiatives in
Member States (MSs) of the European Union (EU), the European Commission as well as international institutions (e.g.
OECD, WHO-EUR). On that basis, we conducted a two-stage online survey, the european Health System_Indicator
(euHS_I) survey. The survey sought to elicit preferences from a wide range of HSPA experts on i) the most relevant
HSPA domain(s), i.e. access, efficiency, quality of care, equity, for a specific indicator, and ii) the importance of indicators
regarding their information content, i.e. headline, operational, explanatory. Frequency analysis was performed.
Results: We identified 2168 health and health system indicators listed in 43 relevant initiatives. After adjusting for
overlaps, a total of 361 indicators were assessed by 28 experts in the 1st stage of the survey. In the 2nd stage, a more
balanced set of 95 indicators was constructed and assessed by 72 experts from 22 EU MSs and 3 non-EU countries. In
the domain access experts assessed share of population covered by health insurance as the top headline indicator. In
the domain efficiency, the highest rank was given to Total health care expenditure by all financing agents, and in the
domain quality of care to rate of hospital-acquired infections. Percentage of households experiencing high levels/
catastrophic of out-of-pocket health expenditures results as the top headline indicator for domain equity.
Conclusions: HSPA indicators from different initiatives largely overlap and public health indicators dominate over
health systems aspects. The survey allowed to quantify overlaps and gaps in HSPA indicators, their expert allocation to
domain areas and establishment of an informed hierarchy structure. Yet, results show that more multidisciplinary work
is needed to ensure the availability of accurate efficiency indicators which are comparable across countries.
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Background
Health system performance assessment (HSPA) is a
topical issue. The World Health Organization (WHO)
describes HSPA as “a country-owned process that allows
the health system to be assessed holistically, a ‘health
check’ of the entire health system” [1]. HSPA has now
received high-level support at national, European Union
(EU) and broader international (WHO, Organisation for
Economic Co-operation and Development - OECD)
levels as an instrument to improve transparency and
accountability [2, 3]. For example, the European Com-
mission’s (EC) communication on effective, accessible
and resilient health systems [4] and the mandate by the
EC President given to the European Commissioner for
Health to develop expertise for HSPA reflect this [5].
While policy making in many areas of EU health
systems is the responsibility of Member States (MSs),
comparisons of health system performance (HSP) have
become increasingly important to foster cross-country
learning. Therefore, the EC supports MSs directly in this
work by providing analysis and forecasts, and recom-
mending reforms based on evidence linked to robust
and comparable information [6–8]. Reflecting generic
policy goals, HSP is measured against multiple objec-
tives. This calls for a strong framework covering access,
efficiency, equity and quality and their interrelation in
order to understand the content and the scope of the
cross-country comparison [9, 10]. In undertaking inter-
national comparisons, it is crucial to have good under-
standing about the strengths and limitations of existing
indicators, and their usefulness in assessing system
performance [11, 12]..
Although notable achievements have been made in
terms of scope, nature and timeliness of performance
data over the last 30 years, methodological challenges
remain. In particular, a European-wide coherent HSPA
framework for cross-country comparison does not exist
[9, 10]. Even though the European Core Health Indica-
tors (ECHI) initiative is an important source of relevant
indicators, creating and unifying reporting standards of
data and indicators [13] with priority information
content is missing [14]. Currently, health and health
system indicators for cross-country comparison exist in
repositories such as ECHI/Eurostat, OECD health statis-
tics and WHO European health information gateway
[15]. A proliferation of HSP indicators at the inter-
national level has evolved for a variety of purposes,
including informing policy development, evaluating
policy initiatives, promoting accountability to citizens,
managerial control, and research. This can cause both
confusion and duplication of effort, and also leads to a
lack of comparability over time and between countries.
Both consequences suggest a need to rationalize the col-
lection and dissemination of indicators if their usefulness
and impact is to be maximized. Having a manageable set
of “leading” or “headline” indicators may provide a
focused system overview at a glance. If aligned to health
(system) strategy goals or a common framework with a
proper definition, they can give early warnings of policy
impacts, highlight trends, indicate priorities for policy
action, and promote accountability. Ideally, they also
foster cross-country learning through stimulating further
analysis [16]. This was already advocated by the inde-
pendent and multidisciplinary Expert Panel on Effective
Ways of Investing in Health (EXPH) [13].
The concept of headline indicators as an important
monitoring tool to track and explain progress toward
strategic targets is well established and has been adopted
in various areas, for example, in the Europe 2020′ strat-
egy [17] and in the area of Sustainable Development
[18]. It is convention in macro-economics where core
indicators of Gross Domestic Product growth, inflation,
unemployment, and current account are standard in
looking at the performance of countries [19]. Also, the
scoreboard of key employment and social indicators
echoes the importance of such concepts [20]. For the
current study, we have adapted these existing concepts
[18, 21] and defined headline indicators of health
systems as being apt to monitor the overall performance
in defined domains related to key objectives in public
health and in health systems. Other criteria include
being robust, widely used with high communicative and
educational values, and available for most EU MSs, gen-
erally for a minimum period of 5 years.
The aim of the paper is to identify overlaps and gaps
in the availability of used and proposed HSP indicators,
and ultimately to provide a set of headline indicators for
HSPA. For this, we conducted a two-stage online survey
and asked experts’ to map existing indicators onto most
appropriate HSPA domain(s) and assess their priority
information content for HSPA. The present work forms
an integral part of the activities of the team working on
the evaluation of health systems within the BRIDGE
Health project (Work Package 12). It draws on previous
research conducted in the FP7 project EuroREACH [10]
and on our earlier paper looking at major HSPA actors
and initiatives at European level [15]. To ensure
consistency with past and existing initiatives and to in-
form the survey design, we established the BRIDGE
Health System Indicator Task Force [22], a body of high
level international experts in the area of HSPA.
The paper is intended both for researchers, as well as
for decision makers and policy advisors at EU and MS
level by summarizing the key findings in terms of the
resulting indicator inventory and the identified “head-
line” indicators which may be used to frame and de-
scribe the performance of a health system across EU
countries. The rest of the paper is organised as follows:
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the Methods section provides details of the applied
methods; in Results we report the main findings followed
by their Discussion and some main Conclusions.
Methods
We comprehensively and systematically reviewed, assessed
and organized the existing health and HSP indicator land-
scape for the EU context using a multi-layer approach.
Inventory of indicators
Firstly, we compiled an inventory by identifying and
including reported indicators in i) HSP initiatives at the
EU, OECD and WHO-EUR levels [15], ii) similar initia-
tives developed at the level of MSs when available in
English and iii) performance work done in Australia,
Canada, New Zealand and US, countries with longstand-
ing experience in the field of HSPA. Based on a previous
focused search conducted by the authors between Octo-
ber 2015 and June 2016 that informed a mapping
exercise of the HSPA landscape at EU level [15], relevant
HSP initiatives at the EU, OECD and WHO-EUR levels
were identified. This search was extended to identify
relevant initiatives at MS level where mapping reports
by the EG HSPA on quality of care [23], country com-
ments of the HSPA Belgium peer-review process [24]
and the health system accountability multi-country study
by WHO-EUR [25] proved useful primary sources to
grey (i.e. institutional websites, reports from national
organisations) and peer-reviewed literature (e.g. scientific
articles describing development of country HSPA
process). For complementing the inventory with an
international perspective, also five institutional websites
of Australian, Canadian and New Zealand ministries of
health and the Commonwealth Fund were searched. We
extracted indicators from initiatives that fulfilled the cri-
terion of informing a blueprint for an indicator repository
of a European health information infrastructure [15].
Indicator names and all reported corresponding
meta-information such as definition, calculation, ration-
ale, and data availability were extracted into an indicator
inventory. The inventory was then organized into a total
of 20 thematic chapters in line with the chapter struc-
tures of the OECD Health at a Glance report from 2015
[26] and the OECD Health Care Quality Indicators
(HCQI) Framework [23, 27]. Overlapping indicators
were consolidated and in some instances (re)classified.
The consolidation was not done through a formal statis-
tical method but by using systematic rules, e.g. eliminate
duplicates with similar definitions or disaggregation
levels and create respective ‘indicator groups/themes’ of
similar indicators with the same denominator but differ-
ent numerator (e.g. health care expenditures by
financing agent, hospital discharges by disease, cancer
screening rates etc.). In addition, we used rules such as
“rather country-specific and/or lack of information/def-
inition”, and “not relevant and/or out of scope” to
consolidate and eliminate further indicators. All steps
were done through structured discussions involving the
core research team and other WP12 partners with ex-
pertise in economics of health, public health, health ser-
vices research, health policy, and mental health. Identical
indicators as well as indicators with similar definitions
or disaggregation levels were collapsed. A complete list
of what we considered to be rather country-specific indi-
cators is provided in Additional file 1.
Developing the european Health System_Indicators
(euHS_I) survey
Secondly, in order to elicit i) the most appropriate HSPA
domain(s) for an indicator, and ii) the indicator’s import-
ance for HSPA based on a pre-defined indicator hier-
archy structure, we conducted a two-stage online survey
in English.
Two organizing principles informed the vertical and
horizontal structure of the euHS_I survey. Reflecting
broad health policy goals, the survey used a stylized
framework covering access, efficiency and quality as
main health system performance domains as well as the
cross-cutting domain of equity [28]. Detailed definitions
of the key concepts of these broad dimensions are pre-
sented in Additional file 2.
For the indicator hierarchy structure, we used the
framework developed by the EU Sustainable Develop-
ment Strategy that proposes a grouping of indicators
according to an assessment of their priority information
content in the form of an indicator pyramid [18]. A
similar three-level approach is used by DG Environment
for measuring resource efficiency. The respective indica-
tor set consists of i) one headline indicator, ii) a dash-
board of complementary indicators, and iii) a set of
theme specific indicators to measure progress towards
the specific objectives and actions [21]. We used this
approach as it highlights headline indicators which
co-exist with larger sets of indicators on operational and
explanatory levels for more comprehensive policy-mak-
ing and monitoring. Also, it avoids creating composite
indicators which are often difficult to interpret [29].
However, headline indicators face the limitation that
they could be used for politics, rather than policy. Spe-
cifically, their choice could reflect current political prior-
ities rather than significant issues influencing future
sustainability. Nevertheless, if they are used correctly,
they have the potential to attract media attention,
raise awareness and more importantly, provide quick
and visible signals to policy-makers and to the general
public [30].
After pilot testing the content, length, clarity, and ease
of use within the HSI Task Force, the 1st stage of the
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anonymized and revised euHS_I survey was conducted
from June to September 2016. This was followed by a
2nd stage from March to May 2017. Our overall partici-
pant sampling frame included all EU MSs, the EC and
international organisations (OECD, WHO), as well as
authors from other included HSPA initiatives from
non-EU countries. In the 1st stage, we surveyed a
selected number of HSPA experts, i.e. persons actively
involved in performance measurement and reporting,
indicator development, or research of HSPA domains.
We further included partners of the BRIDGE Health
consortium, as well as relevant experts from the EC (in-
cluding the Expert Group on HSPA), the OECD and the
WHO-EUR (n = 92). In the 2nd stage, a systematic
selection of 209 experts from 28 EU MSs, 11
non-EUcountries and two international organisations
were asked to complete the survey. Here, the primary
aim was to achieve a high and representative response
rate from expert representatives of MSs and from inter-
national organisations.
Whereas the 1st stage consisted of the full list of the
identified consolidated indicators, the 2nd stage was
reduced to a more balanced set of indicators prioritised
based on the 1st stage results. Prioritisation was done
through backward elimination where all indicators that
received less than three scores as headline indicator in
the 1st stage were excluded (see Fig. 2). While in the 1st
stage the level assessment of indicators was a
multiple-choice format, it was restricted to single choice
in the 2nd stage to enable more conclusive judgment.
Every indicator was accompanied by an explanatory in-
formation that contained the consolidated definition and
a reference list of the source initiative. Furthermore, as a
standalone question at the end of the survey, participants
were asked to rate the importance of 11 proposed criteria
of any headline indicator on a Likert scale of 1–5 (1 = im-
portant, 5 = not important), see Table 1. These criteria
were derived from a synthesis of applicable information
from relevant reviewed initiatives [18, 26, 27, 31–39]. Ul-
timately, participants were asked to optionally list their
top three headline indicators per HSPA domain based on
their individual preferences for reasons of cross-validation
and allowed to provide comments. Overall, we allowed
participants to only assess indicators according to their
Table 1 Definitions of applied indicator (selection) criteria (n = 11)
Criterion Definition Source
(policy) Relevance ● The extent to which the measures represent the most critical issues and priorities of
the health system.
● An indicator measures an aspect of quality with high clinical importance, a high
burden of disease or high health care use.
[18, 27, 31, 34, 35,
37, 38]
Actionability ● Monitors the overall performance related to the attainment of key objectives.
● An indicator measures an aspect that is subject to control by providers and/or the
health care system and is actually used at a national level for policy making, monitoring
or strategy development.
[18, 27, 31–33, 35,
38]
Clear and easy to
communicate &
interpret
● Indicator is widely used with a high communicative and educational value.
● Measure would be easily understood such that the meaning behind the numbers would
be immediately apparent for all stakeholders, from statisticians and measure developers to
students, patients, and other individuals.
[18, 26, 31, 32, 34,
37, 38]
Validity ● Sufficient scientific evidence exists to support a link between the value of an indicator and one or
more aspects of health care quality.
[18, 27, 31–35, 39]
Reliability ● Repeated measurements of a stable phenomenon get similar results. [27, 34, 38, 39]
International
feasibility
● An indicator can be derived for international comparisons without substantial additional
resources.
[18, 27, 34, 38]
International
comparability
● Reporting countries comply with the relevant data definition and where differences in
the indicator values between countries reflect issues in quality of care rather than differences
in data collection methodologies, coding or other non-quality of care reasons.
● It should be possible to compare the indicator over time and ideally between places.
● Comparability is ensured when concepts and definitions follow internationally agreed
standards.
[18, 27, 31, 33, 35,
38]
Routine availability ● The indicator should be available for minimum 5 years for most MS. [18, 26, 31–36, 38,
39]
Far reaching ● A core measure set needs to capture not only progress on the specific measures it includes
but also progress on overarching, meaningful priorities for health across the health system,




● An indicator set should have an appropriate mix of indicators at different monitoring levels;




● A core measure set should comprise the minimum number of measures needed to assess
health and health care system.
[34, 35, 37]
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expertise and made all questions optional to minimize the
dropout rate. Participants were contacted by email and
two reminders were distributed at earliest two and 5
weeks after the initial invitation.
Frequency analysis was performed. Results in this paper
focus on the most frequent “top-level” headline indicators
per HSPA domain. For this we gradually calculated three
types of frequencies which served as ranking principles to
be found in the third column of each table: “HSPA domain
frequencies” (Table 4), “headline level frequencies” (Table 5),
and “individual preferences frequencies” (Table 6). Based
on these frequencies rankings were derived to compile the
top three headline indicators per domain. In case of ties in
the ranking, all indicators are reported and were given the
same rank. Those with the highest ranks among all three
were selected. These are accompanied by a summary of
provided comments. In addition, we report results on
indicator criteria as means with standard deviations and
carried out analysis using chi-squared test.
Results
Inventory of indicators
Altogether, we included 43 relevant national and
international HSPA initiatives coming from the EC
[2, 7, 13, 18, 32, 36, 40–55], the OECD [26, 33, 56, 57], the
WHO [35, 58], and other international institutions
[37, 59–65] and EU MSs [66–78] (Fig. 1). Thirteen
initiatives from Belgium, Estonia, Hungary, Ireland,
Italy, Malta, Netherlands, Portugal, Sweden and
United Kingdom informed the inventory at MS level.
The extraction of indicators resulted in a long list of
2168 reported health and HSP indicators, of which
43% were found in reports from MSs. After excluding
132 indicators considered irrelevant for HSPA and/or
as being too country-specific and adjusting the
remaining 2032 indicators for overlaps, a final list of
361 indicators was included in the 1st stage of the
euHS_I survey. Fig. 2 shows the distribution of this
initial set of consolidated indicators. We found that
Fig. 1 Flow chart with timeline
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indicators listed in the domains quality of care (34%,
121/361), health status (15%, 55/361) and determi-
nants of health (13%, 47/361) dominate the current
HSP indicator landscape. In contrast, indicators of finan-
cing (23/361), physical resources (21/361) and healthcare
activities (23/361) represent only 6% per chapter.
Characteristics of survey responders
Table 2 describes the characteristics of the euHS_I sur-
vey responders by stage. In the 1st stage, we received 28
responses, corresponding to 29% of experts surveyed. Of
the total responses, 10 (36%) were complete and 18
(64%) were partially complete through letting partici-
pants to focus only on domains that matched their
relevant expertise. In the 2nd stage, the overall response
rate was 34% (72 out of 209). This increase was mainly
achieved through an improved and representative
response to the survey coming from EU countries a total
of 79% (22 out of 28). In total, out of the 72 responses
52 (72%) were complete and 20 (28%) were partially
complete.
Responders’ affiliation with a governmental or other
public institution was 50% (n = 14) in the 1st stage and
46% (n = 33) in the 2nd stage representing the biggest
category in both stages. Participation from research
institutions decreased from 43% (n = 12) in the 1st stage
to 36% (n = 26) in the 2nd stage. A considerable level of
expertise in HSPA (defined as a score of 3 or higher) of
responders was observed in both stages, 79% (n = 22) in
the 1st stage and 84% (n = 61) in the 2nd stage. 68% (n
= 19) of respondents of the 1st stage were experts in
health economics which decreased to 26% (n = 19) in the
2nd stage. The 2nd stage had the highest rate of experts
in the area of epidemiology, 51% (n = 37) compared to
the 1st stage, 43% (n = 12). Overall as shown in Table 3,
the mean indicator assessment rate by thematic chapters
increased from 58% (209 out of 361) to 72% (69 out of
95) in the 2nd stage.
Top three indicators ranked by HSPA domain, headline
level and individual preferences
Table 4 lists the most highly ranked HSPA domain indi-
cators which are accompanied by the rank of headline
level and the rank it received based on individual prefer-
ences. In Table 5 the most important indicators by head-
line level are summarized. Table 6 presents the ranking
of top three listed headline indicators by individual pref-
erences of respondents. Indicators which are marked
with a star can be considered as robust “top-level” indi-
cators as their ranks are top, in domain, in headline
level, and in individual preferences. If there are duplicate
values in the ranking, these are given the same rank.
Sample sizes, indicated by N, vary due to differences in
completion rates. Tables 5 and 6 further display the
availabilities in the most common data repositories.
Overall, of those who assessed the respective indicators,
Fig. 2 Distribution of stepwise adjustment of indicator inventory for euHS_I survey
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Table 2 Characteristics of the euHS_I survey responders by stage
Characteristics 1st stage (n = 28) 2nd stage (n = 72)
n % n %
Overall completion ratea
Fully completed 10 36% 52 72%
Partially completed 18 64% 20 28%
Response rate by affiliation
Governmental or other public institution 14 50% 33 46%
Research institution 12 43% 26 36%
International organization 1 4%s 0 0%
Health care provider 1 4% 10 14%
Non-profit organization 0 0% 3 4%
Geographic distribution by regionb
West 13 46% 24 34%
South 7 25% 27 36%
North 5 18% 8 12%
East 2 7% 11 15%
Non-EU 0 0% 2 3%
No response 1 4% 0 0%
Level of HSPA expertise (1 = basic, 5 = expert)
1 (basic) 1 4% 0 0%
2 5 18% 9 13%
3 3 11% 26 36%
4 7 25% 21 29%
5 (expert) 12 43% 14 19%
No response 0 0% 2 3%
Area of expertisec
Chronic Care 7 25% 9 13%
Determinants Of Health 12 43% 32 43%
Economics 8 29% 6 8%
Elderly / Long-Term Care 2 7% 5 7%
Environmental Health 2 7% 14 19%
Epidemiology 12 43% 37 51%
Ethical Issues 0 0% 6 8%
Financing Health Care 13 46% 11 15%
Health Economics 19 68% 19 26%
Health Spending, Cost of Care 14 50% 9 13%
Maternal And Child Health 4 14% 8 11%
Organization and Delivery of Care 9 32% 15 21%
Pharmaceuticals 2 7% 10 14%
Quality of Care 10 36% 24 33%
Workforce Issues 5 18% 4 6%
aRespondents who completed less than 5 indicator were considered as non-responder
bAccording to Eurovoc geographical classification [92]
cThese categories were not mutually exclusive and hence the sum is greater than 100%
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on average only 8% of respondents indicated that they
do not have appropriate expertise in assessing the
relevance and importance of indicators. Explanatory in-
formation of presented headline indicators per HSPA
domain is available in Additional file 3.
Access
Of 66 experts 43 (65%) assessed share of population cov-
ered by health insurance as the top-level headline indica-
tor in this domain. The importance of this indicator was
also highlighted by rankings given through individual
preferences from 9 out of 25 experts (36%). In Table 5,
accessibility to acute care ranks second, assessed by 26
out of 61 (43%) respondents, and 25 out of 62 (40%)
assessed self-reported unmet need which thus ranks
third. Both indicators are also listed in Table 4, but in
reverse order. Interestingly, process indicators on wait-
ing times for access to specialist care and for elective
surgeries only received high priority on second and third
rank when listed individually by respondents.
Efficiency
The ranking shows that mostly input indicators were
ranked high while pushing full efficiency measures (in-
put/output/outcome metric) down. Top three headline
indicators in Table 5 are largely measures of costs such
as 1) total healthcare expenditure by all financing agents
which is identified as a “top-level” indicator, 20 out 41
(49%), and 3) current healthcare expenditure by all
financing agents (total, public and private sectors), 17
out 36 (47%). Among the top two are hospital beds, 18
out of 48 (38%) and vaccination coverage in children, 18
out of 28 (64%) due to a tie in ranking. In ranking top
three preferred headline indicators per HSPA domain
individually at the end of the survey (Table 6), only four
respondents out of 20 (20%) reported an input to out-
come measure as top two, e.g. health expenditures per
capita in PPP (purchasing power parities) in relation to
life expectancy as preferred top one.
Quality of care
1) vaccination coverage in children, 29 out of 44 (66%),
2) infant mortality rates, 26 out of 36 (72%), and 3) ma-
ternal mortality rate, 25 out of 42 (60%) were rated as
top headline indicators in Table 5. On the contrary, re-
sults from the individual ranking preferences show 1)
hospital standardized mortality ratio, 6 out of 24 (25%),
2) ambulatory care sensitive conditions hospitalization
rate, 3 out of 22 (14%), and 3) prevalence and incidence
rate of hospital-acquired infections (HAI), 5 out of 20
(25%) were named as the most top three headline indica-
tors, see Table 6. Besides, two process indicators rate of
patients with colorectal tumour receiving chemotherapy
and screening rates for selected cancers were allocated
on second and third rank for the quality domain in
Table 4. However, a closer look at the different rankings
reveals that the HAI rate, a process indicator, is in the
upper bound of all rankings and consequently identified
as “top-level” headline indicator for this domain.
Equity
The top three headline indicators from Table 5 are 1)
share of population covered by health insurance, 27 out
of 39 (69%), 2) self-reported unmet need for medical
care, 20 out of 42 (48%), and 3) accessibility to acute
care, 19 out of 34 experts (56%). These indicators were
also scored headline in the domain of access indicating
that experts pertained to the concept of equity in access
rather than equity in outcomes. Nevertheless, when the
rankings by HSPA domain (Table 4) and individual prefer-
ences (Table 6) are considered percentage of households
experiencing high levels/catastrophic of out-of-pocket
health expenditures, 43 out of 68 experts (63%) results as
the “top-level” headline indicator.
Health status
1) life expectancy, 35 out of 47 (74%), 2) infant mortality
rate, 30 out of 39 (77%), and 3) healthy life years, 26 out
of 42 (61%) received the highest scores in Tables 4 and 5
(different order). These results are also mirrored by
results of the individual ranking in Table 6 which are
only complemented by avoidable mortality rate deemed
important for the second rank and life expectancy being
the “top-level” headline indicator.
Table 3 Average indicator assessment rate by thematic
chapters of both survey stages
Thematic chapters 1st stage 2nd stage
n %a n %a
Access 30 83% 15 92%
Health care resources 21 73% 5 81%
Health care activities 23 68% 7 80%
Health expenditure & financing 23 64% 8 71%
Quality of Care 121 55% 8 71%
Pharmaceutical 6 53% 0 0%
Ageing and LTC 18 52% 3 69%
Health Status 55 56% 32 64%
Determinants of Health 47 46% 5 62%
Additional info 14 49% 12 63%
Other 3 50% 0 0%
TOTAL 361 58% 95 72%
aThe average number of indicators in percent of the total number of
indicators per chapter included in the survey stages. The number of indicators
varies because of completion preferences by respondents
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Health determinants
Headline results in Table 5 overlapped with headline ac-
cess, equity and health status indicators: 1) share of
population covered by health insurance, 18 out of 32
(56%), 2) life expectancy, 18 out of 26 (69%), and 3) body
mass index, 17 out of 36 (47%). Clearly and more accur-
ately, HSPA domain and individual rankings reveal the
importance of lifestyle specific aspects which rank
among the top 3: prevalence of different smoking status,
8 out of 22 (36%), and participation in early childhood
Table 4 Top three indicators ranked by HSPA domain frequency
















Access Share of population covered
by health insurance
1 1 1 69 96% 43 65%
Self-reported unmet need for
medical care (total by reason:
cost, waiting time, distance)
2 3 na 68 91% 25 40%
Accessibility to acute care 3 2 3 66 92% 26 43%
Efficiency Average length of stay (ALOS),
total and selected diagnoses
1 39 1 58 84% 7 14%
Hospital beds 2 2 na 61 79% 18 38%
Hospital day-cases, total and
selected diagnoses
3 14 na 60 78% 11 23%
Quality
of Care
Prevalence and incidence rate of
hospital-acquired infections (% of
patients hospitalised)
1 4 3 50 90% 21 47%
Vaccination coverage in children 2 1 na 52 85% 29 66%
Rate of patients with colorectal
tumour receiving chemotherapy
whose treatment started within two
months following surgery
2 35 na 65 68% 8 18%
Screening rates for selected cancers
(breast, cervical, colon)
4 5 na 51 84% 29 66%
Equity Percentage of households experiencing
high levels/catastrophic of out-of-pocket
health expenditures
1 7 3 68 63% 14 33%
Self-reported unmet need for medical
care (total by reason: cost, waiting time,
distance)
2 2 na 68 62% 20 48%
Private household out-of-pocket
expenditure as a proportion of total
health expenditure
3 19 na 67 61% 10 24%
Health Status Life expectancy 1 2 1 52 90% 35 74%
Healthy Life Years (HLY) 2 3 1 51 82% 26 62%
Infant mortality rate 3 1 4 50 78% 30 77%
Health
Determinants
At risk of poverty or social
exclusion rate
1 34 na 45 89% 7 18%
Body Mass Index 2 3 2 44 82% 17 47%
Prevalence of different smoking status,
self-reported
2 4 1 43 84% 16 44%
Unemployment rate 4 56 na 45 78% 5 14%
na not available
athe statistical rank of the respective indicator based on the HSPA domain or headline level per HSPA domain frequency. If there are duplicate values in the
ranking, these are given the same rank
bHSPA domain frequencyi d ¼
PN
r¼1 xr ,
cHeadline level per HSPA frequencyi d h ¼
PN
r¼1 yr where i is indicator ID, d is domain name (access / efficiency / equity / quality of care / health status / health
determinants), h is headline level, x is received score for domain, y is received score for headline level, r is questionnaire ID
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Table 6 Top three listed headline indicators ranked by individual preferences















Access Share of population covered by
health insurancea
1 1 1 25 36% ✓ ✓ –
Reported waiting times for access
o specialist (care)
2 5 8 24 17% – – –
Accessibility to acute care 3 3 2 22 18% – – –
Waiting times for elective surgeries 3 8 31 22 18% – ✓ –
Efficiency Average length of stay (ALOS), total
and selected diagnoses
1 1 39 22 14% ✓ ✓ ✓
Total health care expenditure by all
financing agents (total, public and
private sectors)a
1 6 1 22 14% ✓ ✓ ✓
Health expenditure per capita in PPP
(purchasing power parities) in relation
to life expectancy at birth
2 21 34 20 20% ~ ~ ~
Number of surgical operations and
procedures
4 10 55 16 25% ✓ ✓ ✓
Quality of
Care
Hospital Standardized Mortality Ratio
(HSMR)
1 11 12 24 25% ➔ ➔ –
Ambulatory Care Sensitive Conditions
(ACSC) Hospitalization Rate
2 8 15 22 14% – ✓ –
Prevalence and incidence rate of
hospital-acquired infections (% of
patients hospitalised)c
3 1 4 20 25% – – –
Equity GINI coefficient (income distribution) 1 20 48 17 35% ✓ ✓ ✓
Geographic distribution of doctors:
Physicians density in predominantly
urban and rural regions
2 8 7 17 18% ~ ~ ~
Percentage of households experiencing
high levels/catastrophic of out-of-pocket
health expendituresa
3 1 7 17 12% – ✓ –
Self-reported/perceived general health 3 20 15 17 12% ✓ – –
Health Status Healthy Life Years (HLY) 1 2 3 22 18% ✓ ✓ ✓
Life expectancya 1 1 2 22 18% ✓ ✓ ✓
Avoidable mortality rate: amenable and
preventable deaths
2 8 5 20 15% ✓ – –
Infant mortality rate 4 3 1 18 28% ✓ ✓ ✓
Health
Determinants
Prevalence of different smoking status,
self-reporteda
1 2 4 22 36% ✓ ✓ ✓
Body Mass Indexa 2 2 3 19 21% ✓ ✓ ✓
Opportunities for education:
Participation in early childhood
education
3 7 24 17 18% ✓ ✓ –
Overall experience of life: Life
satisfaction
3 20 8 17 18% ✓ ✓ –
arobust indicator with the lowest sum of all three rankings
bthe statistical rank of the respective indicator based on the HSPA domain or headline level per HSPA domain frequency. If there are duplicate values in the
ranking, these are given the same rank. (✓) indicator available, (~) not ready-made and needs to be calculated, (−) not available, (➔) indicator available just for
selected diagnoses
cprovided by ECDC
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education, 3 out of 17 (18%) were attributed a greater
importance, see Tables 5 and 6. Based on these smoking
status and BMI result as being “top-level” headline indi-
cators for health determinants.
Table 5 also shows the availability of the 19 selected
headline indicators in the most common health data
repositories as per September 2017. 84% (16/19) of
top three headline indicators are available in the
ECHI/Eurostat database, 84% (16/19) in the OECD
database, and 63% (12/19) in the WHO-EUR data
gateway.
Headline indicator criteria
Respondents’ average ratings reflecting the importance
of the 11 criteria for a headline indicator are sum-
marised in Table 7. Forty-nine percent of those surveyed
(n = 36) responded to this question. Overall, 9 out of 11
criteria were rated as important (1) or probably import-
ant (2), the top three criteria being validity, reliability
and that an indicator needs to be clear and easy to com-
municate & interpret. While validity was ranked as most
important (Mean = 1.32, SD = 0.48) by participants affili-
ated with a governmental institution, for researchers the
criterion clear and easy to communicate & interpret
had the highest importance (Mean = 1.40, SD = 0.66).
Indicators which are routinely available was most
important for healthcare providers completing the
survey (Mean = 1.00, SD = 0.00). Regarding inter-
national comparability, results show a statistically
significant difference (χ2 test, p < 0.001) between re-
spondents affiliated with governmental institutions
(rank = 3, Mean = 1.47, SD = 0.77) and researchers
(rank = 6, Mean = 1.69, SD = 1.03).
Discussion
This study identified important and relevant “headline”
indicators for HSPA that have potential to focus and
improve cross-country comparisons. Experts’ percep-
tions were also obtained about the most relevant criteria
that should underline the prioritisation of indicators.
The main strength of our study lies in the systematic
and comprehensive approach adapted in mapping the
current EU-relevant HSPA indicator landscape. To en-
hance cross-country knowledge exchange, this was com-
plemented by other international initiatives. Currently,
no similar consolidated indicator inventory does exist.
To strengthen further research in the area, the relevant
database containing the full raw and consolidated list of
indicators has now been made available at websites of
HS&I and the Medical University of Vienna [79].
Our results highlight several main points for further
considerations, especially in the light of some of the
comments respondents provided.
Firstly, the distribution of available indicators is unbal-
anced and dominated by areas such as quality of care,
health status and determinants of health which largely
overlap. These have been driven by policy and research
with the aim to improve health information quality and
availability in the area of public health (e.g. DG Santé-E-
CHI, OECD HCQI). This is also reflected in the recent
call for further progress on the development and use of
patient reported outcome measures (PROMs) which
besides of self-reported health as equity indicator, did
not receive top priority for headline possibly due to lack
of data availability [27, 40, 80–83]. Overall, results from
Table 6 indicate that the distribution of types of indica-
tors (e.g. outcome, process and structural measures) is
rather balanced across HSPA domains, but not within.
Table 7 Priority ranking of headline indicator criteria by respondents’ affiliation
Total (N = 36) Governmental or other
public institution (N = 19)
Health care
provider (N = 2)
Research institution
(N = 15)
Criterion Mean SD Rank P-value * Mean SD Rank Mean SD Rank Mean SD Rank
Validity 1.36 0.54 1 0.769 1.32 0.48 1 1.50 0.71 2 1.40 0.75 2
Reliability 1.44 0.61 2 0.986 1.44 0.62 2 1.50 0.71 3 1.44 0.51 3
Clear and easy to communicate & interpret 1.50 0.56 3 0.466 1.53 0.61 4 2.00 0.00 7 1.40 0.66 1
International comparability 1.65 0.79 4 0.000 1.47 0.77 3 3.00 1.41 9 1.69 1.03 6
Actionability 1.70 0.62 5 0.936 1.68 0.58 6 2.50 0.71 8 1.63 0.60 5
Policy relevance 1.72 0.70 6 0.231 1.67 0.69 5 1.50 0.71 4 1.81 0.82 7
Routine availability 1.72 0.61 7 0.830 1.68 0.58 7 1.00 0.00 1 1.81 1.45 8
Coherent and balanced overall 1.72 0.66 8 0.654 1.84 0.69 9 1.50 0.71 5 1.60 0.62 4
International feasibility 1.92 1.04 9 0.011 1.68 1.11 8 3.50 0.71 10 2.00 0.63 9
Farreaching 2.31 0.86 10 0.325 2.28 0.67 10 1.50 0.71 6 2.44 0.63 10
Minimum number of indicators 2.64 1.27 11 0.805 2.53 1.17 11 3.50 0.71 11 2.67 0.63 11
SD standard deviation
* chi-square test
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Furthermore, some indicators refer to macro level areas
(e.g. health expenditure) whereas others relate to more
meso level aspects (e.g. hospital sector). Again, these
might be explained by the data availability as a driver for
respondent’s assessment. As for the indicator vaccination
coverage in children, respondents underlined its high
relevance (Q11) as well as suggestions to break down by
socioeconomic status (Q28). Regarding the maternal
mortality rate it was mentioned that due to incomplete
data this indicator is less suitable for evaluation purposes
(Q11) and remains debatable whether it qualifies as a
good headline indicator. Lifestyle indicators (e.g. obesity,
smoking and alcohol consumption) received high prior-
ity on headline level only through individual preferences
and when assessed for specific HSPA domain as many
respondents were experts in epidemiology and health
determinants. Overall the top indicator list benefited
from looking at all three types of frequency rankings.
For example, smoking status would not have made it to
the list although it is a key health determinant while life
expectancy would have been inaccurately mapped as a
health determinant.
Secondly, efficiency indicators which combine out-
come with input measures are rare, they are not often
used and appear not well understood. While both, the
EU Health Strategy “Together for Health” [84] and the
official EC communication [4], referred to the high
importance of efficiency, there is much work still to be
done in developing metrics that are able to compare
health system efficiency across countries [16, 85]. This
reflects difficulties in agreeing on information standards
and protocols and defining adequate outcome metrics to
be combined with input metrics. Our findings suggest
that more multidisciplinary work is needed to enhance
efforts in making accurate, cross-country comparable
efficiency indicators available for comprehensive HSPA
[86]. This is echoed in the 2018 work programme of the
Expert Group on HSPA, a forum where MSs exchange
experiences on the use of HSPA at national level and
which looks specifically at tools and methodologies to
assess efficiency [87].
Thirdly, our findings are in line with the global priority
areas reflected in the Sustainable Development Goals
from 2015 [88]. Considering access to healthcare, it
confirms the ultimate importance of financial protection
in achieving comprehensive universal health insurance
coverage. When looking at comments of survey partici-
pants, several related aspects were addressed. For
example, one respondent said that due to mandatory full
coverage of the population in some countries this indica-
tor might not be a suitable measure of performance
(Q28). Also some concerns on self-reported unmet need
were raised mirroring a widespread scepticism towards
self-assessed health [14]. Due to its huge differences
between the results from the European Union Statistics
on Income and Living Conditions (EU-SILC) and the
Health Interview Survey (HIS) respondents indicate that
this subjective indicator is difficult to interpret (Q15,
Q60), and thus misses to provide actionable information
which weakens suitability for international comparison
(Q3). Others indicated, that the headline suitability for
the indicator accessibility to acute care also depends first
on a clear definition and further on countries’ health
system design where a decline or failure is unmeasurable
because it is incorporated into law, e.g. percentage of
people who can reach primary, emergency and maternity
care services is guaranteed within 20 min (Q26). It was
suggested to look at the distribution across geographical
areas, in relation to deprivation index to increase action-
ability of this indicator (Q36). Further, one respondents
said that “substantial amount of analysis and decisions
regarding health are taken at sub-national level and
many policies and investments that affect population
health are set regionally” (Q30). This reflects the import-
ance the availability of high quality regional level indica-
tors suitable for performance assessment on individual
country level. Finally, we were able to show the feasibil-
ity of indicator priority elicitation across many stake-
holders and the potential to make priority setting more
evidence-based, as required in a recent analysis of prior-
ity setting methods in health information [89]. With this
survey we were able to identify potential so-called
“top-level” headline indicators that appear in all, HSPA
domain, headline level and individual preference fre-
quency which not only matter to policy makers, but also
to people. We believe that the level of coverage of risks
is important to people, mirrored also by the indicator of
private / out of pocket payments listed in Table 6. Even
though many criteria need to be considered and criteria
priority vary depending on the targeted audience, head-
line information on health systems is crucial. Neverthe-
less, the applied method may also be used at country
level and even at provider level as many MSs have a
regionalized health system. A prioritized set of agreed
and robust indicators might serve decision makers infor-
mation needs to compare and potentially benchmark
regional health systems which can encourage the
provision of good quality data from stakeholders [90].
Limitations
This study has a number of limitations.
Firstly, the overall response rate was moderate. This
may be explained by the survey length and the unprece-
dented approach to define headline indicators in the
health sector. In the 2nd stage, a representative
response rate from 22 EU MSs was achieved. While
no response was received from Denmark, Estonia,
Greece, Liechtenstein, Malta and Poland in the 2nd
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stage, representatives from Denmark and Malta
participated in the 1st stage of the euHS_I survey.
Due to the small sample size of healthcare providers,
however, caution must be applied in regard to the
representativeness of our findings in terms of all
different stakeholder groups.
Secondly, validation of results, i.e. assessment based
on the ranked indicator criteria such as data availability
across MSs, and the investigation of collinearity between
the shortlisted indicators has not been performed at this
stage. At the same time, 47 out of 95 (49.5%) included
indicators in the 2nd stage and 84% identified as
headline are coming from ECHI which have predefined
standards and are mostly fed by Eurostat data. Further
validation of the results regarding their usefulness in
assessing system performance for policy makers through
qualitative interviews is also in progress.
Thirdly, our sample size does not allow for further
statistical analyses exploring potential differences in
responses across participants from different countries
and across groups with different types of experience and
potential adjustment to our rankings according to these.
A more comprehensive coverage of experts and multiple
responses from individual countries, however, would
have required substantially larger research resources that
were not available for the current project.
Fourthly, there are likely several biases. Expert back-
ground from authors is health economics, health ser-
vices research/health policy, and mental health which
might have introduced a bias towards the outcome of
the process in consolidating the indicators inventory for
overlaps. This could have caused some unintended am-
biguous indicator groupings by theme chapters. There-
fore, the provided explanatory information to survey
participants and the published full inventory [79] is very
essential in increasing the transparency of this research.
Furthermore, the expertise of respondents has appar-
ently influenced the outcomes of the study (e.g. a high
number of health economics in the 1st stage and a low
number of experts on long-term care or pharmaceuticals
in both stages). The basket of identified headline indica-
tors does not contain any indicator on long term care
although it is a significant contributor to health system
expenditures. It appears that long-term care is not often
not seen as part of a health system because it belongs to
the broader social policy agenda in many countries. Sur-
prisingly, indicators of pharmaceutical care also didn’t
make it to the top list although the cost pressure coming
from these products is high. At the same time indicators
in these areas are given operational or explanatory func-
tion. This indicates the awareness of respondents that
they are important for a more in-depth analysis of
specific policy aspects. Our results will be validated with
policy-makers in a qualitative approach to reflect all
topical health policy aspects which aims to broaden our
understanding of the relevance of indicators and their
importance. Finally, while participants had good
pre-knowledge and thorough expertise with HSPA
indicators it is likely that subjective bias may have influ-
enced individual responses.
Recommendations for future research
In line with Europe 2020’s headline indicators [17], we
suggest the establishment of a similar structure in the
area of HSPA. For example, an electronic repository
could be created featuring headline and lower level
indicators as classified to provide timely benchmarks fol-
lowing the example of the macro-economic database
AMECO of EC’s Directorate General for Economic and
Financial Affairs [91]. Maintained and up-dated timely
with short-term forecasts of key indicators, such an
inventory would be indispensable for analysis and
reporting. In fact, it would improve the overall value of
information provided [14].
Our research has raised many questions in need of
further investigation. Further research should be done to
investigate where improved information through new
indicator development would lead to biggest improve-
ments in decision-making, measured for example by
burden of disease. Likewise, there is abundant room for
further progress in determining the suitability and suffi-
ciency of proxy indicators for certain purposes. More
broadly, this would require addressing the issue of costs
of collecting indicators and assessing their “value of in-
formation” to determine the incremental benefits [14].
Conclusions
The results of our research may provide a blueprint for
most important and relevant “headline” indicators which
may be used in framing and describing the performance
of a health system in the EU context at a first glance.
This should eventually lead to an informative refinement
of the ECHI shortlist. Our study has proposed struc-
tured priority elicitation across many stakeholders and
contributes to evidence-based, multi-sectorial priority
setting methods. Moreover, our findings encourage more
multidisciplinary work to increase the availability of ac-
curate indicators for cross-country comparisons in the
area of efficiency to promote comprehensive HSPA.
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